Misuse of Drugs (Amendment of Schedule 2 to Law) (Jersey) Order 2009

Made                                                                   16th November 2009

Coming into force                                               23rd November 2009

THE MINISTER FOR HEALTH AND SOCIAL SERVICES, in pursuance of Article 3(2) of the Misuse of Drugs (Jersey) Law 1978[1], orders as follows –

1        Interpretation

In this Order “Law” means the Misuse of Drugs (Jersey) Law 1978[2].

2        Part 2 of Schedule 2 to Law amended

At the end of paragraph 1 of Part 2 of Schedule 2 to the Law there shall be added the following sub-paragraphs –

“(c)    any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1- naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(d)     any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(e)     any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;

(f)      any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent;

(g)     any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not substituted in the cyclohexyl ring to any extent.”.

3        Part 3 of Schedule 2 to Law amended

In paragraph 1 of Part 3 of Schedule 2 to the Law –

(a)     before the entry “Alprazolam” there shall be inserted the sub-paragraph number “(a)”;

(b)     after the entry “N-Ethylamphetamine” there shall be inserted the following sub-paragraphs –

“(b)    1-benzylpiperazine;

(c)     any compound structurally derived from 1-benzylpiperazine or 1-phenylpiperazine by modification in either of the following ways –

(i)      by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl substituents,

(ii)      by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl substituents;

(d)     3,4-methylenedioxymethcathinone (Methylone);

(e)     3-keto-3,4-methylbenzodioxylbutanamine (Butylone);

(f)      4-methylmethcathinone (Mephedrone).”.

4        Citation and commencement

This Order may be cited as the Misuse of Drugs (Amendment of Schedule 2 to Law) (Jersey) Order 2009 and shall come into force 7 days after it is made.

deputy a.e. pryke of trinity

Minister for Health and Social Services

 


 



[1]                                    chapter 08.680

[2]                                    chapter 08.680


Page Last Updated: 25 Apr 2016